Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Janssen Biotech, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have moderate-to-severe ulcerative colitis of at least 3 months' duration prior to enrollment, confirmed by endoscopy at any time in the past
For enrollment into the Simponi-exposed cohort meets one of the following:
1. The participant is currently receiving Simponi ,or
2. The participant is continuing to receive Simponi after participation in an ulcerative colitis study, or
3. The participant is scheduled to receive Simponi within 30 days after enrollment
For Thiopurine cohort:
1. The participant is currently receiving thiopurines, having received at least 12 consecutive weeks of therapy prior to registry entry
2. Participant must not be receiving other approved biologic agents, including Simponi, or any investigational agents at enrollment
3. Participant may have received biologics other than Simponi or investigational agents prior to enrollment
You may not be if
Participants who cannot be treated with Simponi or thiopurines
Participants with a previous diagnosis of lymphoma or hematologic malignancy at any time prior to enrollment
Participants currently receiving an investigational or biologic agent other than Simponi
Participants with any condition for which, in the opinion of the investigator, participation in the registry would not be in the best interest of the participant or that could prevent, limit, or confound the protocol-specified assessments
Clareo Health | An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
